Chugai Pharmaceutical Co (TSE:4519) Days Inventory

: 273.05 (As of Dec. 2023)

View and export this data going back to 1956. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Chugai Pharmaceutical Co's Average Total Inventories for the three months ended in Dec. 2023 was 円275,472 Mil. Chugai Pharmaceutical Co's Cost of Goods Sold for the three months ended in Dec. 2023 was 円92,060 Mil. Hence, Chugai Pharmaceutical Co's Days Inventory for the three months ended in Dec. 2023 was 273.05.

The historical rank and industry rank for Chugai Pharmaceutical Co's Days Inventory or its related term are showing as below:

TSE:4519' s Days Inventory Range Over the Past 10 Years
Min: 192 Med: 228.24 Max: 255.1
Current: 245.23

During the past 13 years, Chugai Pharmaceutical Co's highest Days Inventory was 255.10. The lowest was 192.00. And the median was 228.24.

TSE:4519's Days Inventory is ranked worse than
76.31% of 975 companies
in the Drug Manufacturers industry
Industry Median: 157.96 vs TSE:4519: 245.23

Chugai Pharmaceutical Co's Days Inventory increased from Dec. 2022 (129.69) to Dec. 2023 (273.05). It might indicate that Chugai Pharmaceutical Co's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Chugai Pharmaceutical Co's Inventory Turnover for the three months ended in Dec. 2023 was 0.33.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Chugai Pharmaceutical Co's Inventory-to-Revenue for the three months ended in Dec. 2023 was 1.01.

Chugai Pharmaceutical Co Days Inventory Historical Data

The historical data trend for Chugai Pharmaceutical Co's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

224.62

234.92

211.96

192.00

249.79

Chugai Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory																129.69	172.17	271.41	317.09	273.05

Competitive Comparison

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chugai Pharmaceutical Co Days Inventory Distribution

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Days Inventory distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Days Inventory falls into.

Chugai Pharmaceutical Co Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Chugai Pharmaceutical Co's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (292206	+	273480)	/	2 )	/	413306	*	365
=	282843					/	413306	*	365
=	249.79

Chugai Pharmaceutical Co's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (277463	+	273480)	/	2 )	/	92060	*	365 / 4
=	275471.5					/	92060	*	365 / 4
=	273.05

Chugai Pharmaceutical Co (TSE:4519) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Chugai Pharmaceutical Co's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	92060	/	275471.5
	=	0.33

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Chugai Pharmaceutical Co's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	275471.5	/	273812
	=	1.01

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Chugai Pharmaceutical Co Days Inventory Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co (TSE:4519) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (TSE:4519) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

CHGCY:USA CHGCF:USA CUP:Germany

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and COVID-19.

Chugai Pharmaceutical Co (TSE:4519) Headlines

No Headlines